title: Severe urticaria due to recombinant interferon beta-1a.
authors.forename: L
authors.initials: L
authors.lastname: Mazzeo
authors.forename: L
authors.initials: L
authors.lastname: Ricciardi
authors.forename: M C
authors.initials: MC
authors.lastname: Fazio
authors.forename: O
authors.initials: O
authors.lastname: Fogliani
authors.forename: R
authors.initials: R
authors.lastname: Fedele
authors.forename: E
authors.initials: E
authors.lastname: Ferlazzo
authors.forename: S
authors.initials: S
authors.lastname: Isola
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000328:Adult; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000009:adverse effects*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy; D011994:Recombinant Proteins / Q000009:adverse effects; D014581:Urticaria / Q000139:chemically induced*
chemical_list: D000276:Adjuvants, Immunologic; D011994:Recombinant Proteins; D016899:Interferon-beta; D000068556:Interferon beta-1a